IMMUNOMEDICS INC - COM (IMMU)

Historical Holders from Q1 2014 to Q4 2021

Type / Class: Equity / COM
Symbol: IMMU

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2021 Q4	0	$0	-$15,000				0
2021 Q3	430	$15,000				$34.88	1
2020 Q4	0	$0	-$17,222,743,434	$0	$0		0
2020 Q3	202,864,332	$17,249,894,434	+$350,642,519	$252,266,000	$304,661,000	$85.03	408
2020 Q2	205,149,902	$7,270,055,685	+$1,020,157,424	$55,731,000	$160,992,000	$35.44	308
2020 Q1	178,002,093	$2,399,471,203	+$52,357,240	$14,777,000	$25,862,000	$13.48	211
2019 Q4	172,548,773	$3,651,190,625	+$235,061,387	$37,159,000	$72,586,000	$21.16	240
2019 Q3	161,792,617	$2,145,942,109	-$124,088,594	$22,281,000	$61,602,000	$13.26	203
2019 Q2	171,484,130	$2,378,420,592	-$76,396,396	$9,083,000	$57,796,000	$13.87	201
2019 Q1	175,316,698	$3,367,666,410	+$314,560,715	$16,257,000	$54,850,000	$19.21	197
2018 Q4	162,296,825	$2,317,031,125	+$117,562,530	$115,650,000	$81,552,000	$14.27	199
2018 Q3	147,940,971	$3,081,594,094	+$9,562,009	$130,477,000	$87,498,000	$20.83	202
2018 Q2	147,331,837	$3,487,276,565	+$558,631,521	$128,814,000	$94,515,000	$23.67	191
2018 Q1	125,551,220	$1,834,454,941	+$27,037,220	$58,784,000	$75,288,000	$14.61	168
2017 Q4	123,289,987	$1,992,405,979	+$117,182,149	$68,258,000	$127,575,000	$16.16	155
2017 Q3	115,941,624	$1,620,592,334	+$436,517,339	$40,015,000	$55,809,000	$13.98	148
2017 Q2	86,778,024	$766,250,678	+$180,125,997	$23,221,000	$25,713,000	$8.83	129
2017 Q1	68,037,614	$440,110,027	+$135,960,219	$6,770,000	$12,020,000	$6.47	124
2016 Q4	60,203,263	$220,958,216	+$34,366,937	$2,571,000	$10,118,000	$3.67	106
2016 Q3	51,365,525	$166,883,340	+$384,948	$2,232,000	$6,449,000	$3.25	98
2016 Q2	51,961,320	$120,541,255	+$8,402,235	$1,824,000	$5,099,000	$2.32	108
2016 Q1	48,281,655	$120,544,000	+$1,702,334	$623,000	$1,291,000	$2.50	87
2015 Q4	47,064,809	$144,472,341	+$20,889,736	$1,998,000	$6,491,000	$3.07	91
2015 Q3	40,081,358	$68,934,741	-$19,618,823	$1,082,000	$1,832,000	$1.72	76
2015 Q2	40,964,721	$166,297,248	+$4,037,665	$10,401,000	$11,641,000	$4.06	85
2015 Q1	39,658,061	$151,885,590	+$3,202,828	$4,354,000	$7,921,000	$3.83	83
2014 Q4	38,750,455	$185,936,210	+$7,752,108	$2,768,000	$4,745,000	$4.80	83
2014 Q3	36,432,178	$135,482,165	-$3,046,185	$2,342,000	$2,113,000	$3.72	79
2014 Q2	37,114,984	$135,433,313	+$10,947,607	$2,747,000	$1,672,000	$3.65	73
2014 Q1	34,071,971	$143,404,668	+$9,524,379	$3,730,000	$2,786,000	$4.21	73